CN Patent
CN115594591A — 一种催化不对称氢化制备哌仑他韦中间体的方法
Assigned to Shenzhen Catalys Technology Co Ltd · Expires 2023-01-13 · 3y expired
What this patent protects
Patent listed against Mavyret.
Drugs covered by this patent
- Mavyret (GLECAPREVIR) · AbbVie
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.